Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry represents a processed pseudogene related to the human ribosomal protein L36a (RPL36A). Processed pseudogenes arise from the reverse transcription and integration of mature mRNA, lacking introns and typically not encoding functional protein. In humans, there are multiple pseudogenes of RPL36A dispersed across the genome. These pseudogenes, including those with Ensembl gene IDs like ENSG00000239719, do not produce functional protein and are not considered therapeutic targets, nor are they associated with disease or drug interactions. The functional RPL36A gene encodes a component of the cytoplasmic 60S ribosomal subunit essential for protein synthesis, but this does not apply to its pseudogenes[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene.